Novartis Pharmaceuticals secured dismissal of punitive damages demands in the Middle District of Florida, joining the vast majority of other courts in the Aredia/Zometa litigation in holding that New Jersey...
Novartis Pharmaceuticals Corporation achieved a victory when Judge Jessica Mayer granted Novartis’s motions to exclude a plaintiff’s case-specific expert and for summary judgment in one of four cases selected for...
In its opinion, the U.S. Court of Appeals for the District of Columbia affirmed a series of district court rulings dismissing the large majority of claims brought by three Ecuadorian...
The U.S. Court of Appeals for the Fifth Circuit affirmed a summary judgment ruling in favor of Novartis Pharmaceuticals Corporation dismissing all of the plaintiff’s claims in a pharmaceutical products...
Following a full day’s deliberations, a federal jury in Raleigh, North Carolina, returned a unanimous verdict in favor of Novartis Pharmaceuticals Corporation after a seven-day trial involving Aredia and Zometa,...
The U.S. District Court for the District of Minnesota granted summary judgment in favor of Firm client Novartis Pharmaceuticals Corporation (“Novartis”) on all “generics liability” claims in the pharmaceutical products...
Norfolk Southern Railway obtained complete victory on its contractual claims against Westchester Fire Insurance Company (“Westchester”) in a coverage dispute in the U.S. District Court for the Southern District of...
The Ninth Circuit affirmed the District Court’s award of summary judgment in favor of Novartis Pharmaceuticals Corporation (“Novartis”) in the pharmaceutical products liability case, Luttrell v. Novartis Pharm. Corp., No....
Porter Hayden prevailed on a significant coverage dispute when the U.S. District Court for the District of Maryland confirmed that Maryland’s “horizontal exhaustion” rule requires only exhaustion of the primary...
Three weeks before a scheduled trial, the U.S. District Court for the Eastern District of Tennessee granted summary judgment for Novartis Pharmaceuticals in Payne v. Novartis Pharm. Corp., No. 1:12-CV-77...
The U.S. District Court for the District of Arizona granted Novartis Pharmaceuticals Corporation’s (“NPC”) motion for summary judgment based on adequacy of warnings and lack of proximate (or “warnings”) causation...
The U.S. District Court for the Western District of Oklahoma granted Novartis Pharmaceuticals Corporation’s motion for summary judgment in Shrum v. Novartis Pharm. Corp., Case No. CIV-12-1057-C (W.D. Okla. June...
After a two-week long trial, a jury in the Eastern District of California returned a verdict in favor of Novartis Pharmaceuticals Corporation in Hill v. Novartis Pharm. Corp., No. 1:06-cv-00939-JSR-SAB...
The U.S. District Court for the Western District of Louisiana granted Novartis Pharmaceuticals Corporation’s Daubert motion and so excluded plaintiff’s causation expert witnesses and then granted summary judgment in favor...
The U.S. District Court for the Southern District of Georgia granted Novartis Pharmaceuticals Corporation’s motion for summary judgment in Wheeler v. Novartis Pharm. Corp., Case No. 1:11-cv-00211 (S.D. Ga. May...
